HealthMyne, a Madison-based startup that develops software for cancer care, has raised $15 million in new funding.
The Series B round was led by Missouri-based Ascension Ventures, and included participation from local investors Venture Investors, 4490 Venture and WARF. HealthMyne has now raised more than $26 million since it was founded in 2013.
The new funding will allow HealthMyne to expand commercialization efforts for its software platform that gives doctors analytics for medical imaging to help better treat cancer. HealthMyne's data is able to give physicians more information about the tumors they're treating, such as volume, density, mass and doubling-times.
"Imaging data offers a tool that’s been significantly underleveraged for care and disease management,” John Kuelper, investment director at Ascension Ventures, said in a statement. “Only a fraction of the available structural information is actually captured in the radiology report and made available to care teams ... The HealthMyne platform offers a technical infrastructure capable of consistently capturing data at scale."
The startup last raised a $6.9 million round in 2016. It was founded by Rock Mackie, a University of Wisconsin-Madison medical physicist and serial entrepreneur. Mackie sold his previous business TomoTherapy for around $277 million in 2011.
HealthMyne has tested its technology at places like the University of Wisconsin Hospital and Clinics and Moffitt Cancer Center in Tampa.
